Lubiński J - Search Results

1

Sulforaphane-mediated induction of a phase 2 detoxifying enzyme NAD(P)H:quinone reductase and apoptosis in human lymphoblastoid cells.

Misiewicz I, Skupińska K, Kowalska E, Lubiński J, Kasprzycka-Guttman T. Misiewicz I, et al. Among authors: lubinski j. Acta Biochim Pol. 2004;51(3):711-21. Acta Biochim Pol. 2004. PMID: 15448733

2

Molecular basis of inherited predispositions for tumors.

Lubiński J, Górski B, Kurzawski G, Jakubowska A, Cybulski C, Suchy J, Debniak T, Grabowska E, Lener M, Nej K. Lubiński J, et al. Acta Biochim Pol. 2002;49(3):571-81. Acta Biochim Pol. 2002. PMID: 12422228 Review.

3

Inhibition of cell cycle and induction of apoptosis by sulforaphane in cell lines carrying various inherited BRCA1 mutations.

Misiewicz I, Kozar A, Skupinska K, Kowalska E, Lubinski J, Kasprzycka-Guttman T. Misiewicz I, et al. Among authors: lubinski j. Oncol Rep. 2005 Apr;13(4):659-65. Oncol Rep. 2005. PMID: 15756439

4

Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography.

Kurzawski G, Safranow K, Suchy J, Chlubek D, Scott RJ, Lubiński J. Kurzawski G, et al. Among authors: lubinski j. J Biochem Biophys Methods. 2002 Mar 4;51(1):89-100. doi: 10.1016/s0165-022x(02)00003-9. J Biochem Biophys Methods. 2002. PMID: 11879922

5

Clinical characteristics of hereditary ovarian cancer (HOC) in Poland.

Menkiszak J, Górski B, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Foszczyńska-Kłoda M, Fliciński J, Brzosko M, Rzepka-Górska I, Lubiński J. Menkiszak J, et al. Among authors: lubinski j. Ginekol Pol. 2002 Sep;73(9):733-9. Ginekol Pol. 2002. PMID: 12602271

6

Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.

Jakubowska A, Narod SA, Goldgar DE, Mierzejewski M, Masojć B, Nej K, Huzarska J, Byrski T, Górski B, Lubiński J. Jakubowska A, et al. Among authors: lubinski j. Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):457-9. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12750242

7

Germline 657del5 mutation in the NBS1 gene in breast cancer patients.

Górski B, Debniak T, Masojć B, Mierzejewski M, Medrek K, Cybulski C, Jakubowska A, Kurzawski G, Chosia M, Scott R, Lubiński J. Górski B, et al. Among authors: lubinski j. Int J Cancer. 2003 Sep 1;106(3):379-81. doi: 10.1002/ijc.11231. Int J Cancer. 2003. PMID: 12845677

8

Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin.

Debniak T, Górski B, Cybulski C, Jakubowska A, Kurzawski G, Lener M, Mierzejewski M, Masojć B, Medrek K, Kładny J, Załuga E, Maleszka R, Chosia M, Lubiński J. Debniak T, et al. Among authors: lubinski j. Melanoma Res. 2003 Aug;13(4):365-70. doi: 10.1097/00008390-200308000-00005. Melanoma Res. 2003. PMID: 12883362

9

Hereditary ovarian cancer in Poland.

Menkiszak J, Gronwald J, Górski B, Jakubowska A, Huzarski T, Byrski T, Foszczyńska-Kłoda M, Haus O, Janiszewska H, Perkowska M, Brozek I, Grzybowska E, Zientek H, Góźdź S, Kozak-Klonowska B, Urbański K, Miturski R, Kowalczyk J, Pluzańska A, Niepsuj S, Koc J, Szwiec M, Drosik K, Mackiewicz A, Lamperska K, Strózyk E, Godlewski D, Stawicka M, Waśko B, Bebenek M, Rozmiarek A, Rzepka-Górska I, Narod SA, Lubiński J. Menkiszak J, et al. Among authors: lubinski j. Int J Cancer. 2003 Oct 10;106(6):942-5. doi: 10.1002/ijc.11338. Int J Cancer. 2003. PMID: 12918074

10

Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers.

Górski B, Debniak T, Jakubowska A, Cybulski C, Huzarski T, Byrski T, Złowocka E, Lubiński J. Górski B, et al. Among authors: lubinski j. J Appl Genet. 2003;44(3):419-23. J Appl Genet. 2003. PMID: 12923317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results